015: Subtype Specific Stratification and Targeting of Pancreatic Adenocarcinoma

HIPO Investigator:

Prof. Andreas Trummp

Dr. Martin Sprick

Prof. Roland Eils

Prof. Wilko Weichert

Dr. Jens Werner

Supported by: HIPO/POP

Entity: Pancreatic Adenocarcinoma (PDAC)

Publications:

Noll EM et al.; CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma, Nat. Med. 2016

Espinet E et al.; Cellular deconvolution and expression analysis of Stromal and Epithelial cells directly isolated from human Pancreatic Ductal Adenocarcinoma (PDAC); Pancreatology 2017